| Authors: |
Pearson ADJ; ACCELERATE, Europe. Electronic address: andy1pearson@btinternet.com., Rossig C; University Children´s Hospital Muenster, Pediatric Hematology and Oncology, Germany., Lesa G; Paediatric Medicines Office, Product Development Scientific Support Department, European Medicines Agency, Amsterdam, the Netherlands., Diede SJ; Merck & Co., Inc., Kenilworth, NJ, USA., Weiner S; Children's Cause for Cancer Advocacy, USA., Anderson J; UCL Great Ormond Street Institute of Child Health, UK., Gray J; Southampton University NHS Trust, UK., Geoerger B; Gustave Roussy Cancer Centre, France., Minard-Colin V; Gustave Roussy Cancer Centre, France., Marshall LV; Royal Marsden Hospital & Institute of Cancer Research, UK., Smith M; National Institutes of Health, USA., Sondel P; The University of Wisconsin, Madison WI, USA., Bajars M; EMD Serono, USA., Baldazzi C; Tesaro, USA., Barry E; Pfizer, USA., Blackman S; ACCELERATE, Europe., Blanc P; Imagine for Margo, Unite2Cure, France., Capdeville R; Novartis, Switzerland., Caron H; Roche, Switzerland., Cole PD; Rutgers Cancer Institute of New Jersey, USA., Jiménez JC; Agencia Espanola de Medicamentos y Productos Sanitarios and European Medicines Agency, Committee for Medicinal Products for Human Use, Amsterdam, the Netherlands., Demolis P; Agence Nationale de Sécurité du Médicament et des Produits de Santé and European Medicines Agency, Scientific Advice Working Party and Oncology Working Party, Amsterdam, the Netherlands., Donoghue M; Food and Drug Administration, USA., Elgadi M; Boehringer-Ingelheimm Pharma GmbH, Germany., Gajewski T; University of Chicago, USA., Galluzzo S; Agenzia Italiana del Farmaco and European Medicines Agency, Paediatric Committee, Amsterdam, the Netherlands., Ilaria R Jr; Celgene, USA., Jenkner A; Ospedale Pediatrico Bambino Gesù and European Medicines Agency, Paediatric Committee, Amsterdam, the Netherlands., Karres D; Paediatric Medicines Office, Product Development Scientific Support Department, European Medicines Agency, Amsterdam, the Netherlands., Kieran M; BMS, USA., Ligas F; Paediatric Medicines Office, Product Development Scientific Support Department, European Medicines Agency, Amsterdam, the Netherlands., Lowy I; Regeneron, USA., Meyers M; Syndax Pharmaceuticals, USA., Oprea C; Sanofi, France., Peddareddigari VGR; Autolus, UK., Sterba J; University Hospital Brno and European Medicines Agency, Paediatric Committee, Amsterdam, the Netherlands., Stockman PK; AstraZeneca, UK., Suenaert P; Immunicum AB, Sweden., Tabori U; Hospital for Sick Children, Toronto, Canada., van Tilburg C; KiTZ Clinical Trial Unit, Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany., Yancey T; Beigene, China., Weigel B; University of Minnesota, USA., Norga K; Universitair Ziekenhuis Antwerpen, Belgium., Reaman G; Food and Drug Administration, USA., Vassal G; Gustave Roussy Cancer Centre, France. |
